The 40-Gene Expression Profile Test Identifies Patients with National Comprehensive Cancer Network High-Risk Cutaneous Squamous Cell Carcinoma at High Risk of Poor Outcomes to Inform Management Decisions. (2025). SKIN The Journal of Cutaneous Medicine, 9(4), 2426-2443. https://doi.org/10.25251/mvr2rn83